000 01648 a2200469 4500
005 20250518085735.0
264 0 _c20200420
008 202004s 0 0 eng d
022 _a1098-2744
024 7 _a10.1002/mc.23167
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYang, La-Wei
245 0 0 _amiR-155 increases stemness and decitabine resistance in triple-negative breast cancer cells by inhibiting TSPAN5.
_h[electronic resource]
260 _bMolecular carcinogenesis
_c04 2020
300 _a447-461 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntimetabolites, Antineoplastic
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDecitabine
_xpharmacology
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGene Knockdown Techniques
650 0 4 _aHumans
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aNeoplastic Stem Cells
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTetraspanins
_xgenetics
650 0 4 _aTriple Negative Breast Neoplasms
_xgenetics
700 1 _aWu, Xian-Jin
700 1 _aLiang, Yi
700 1 _aYe, Guang-Qing
700 1 _aChe, Yu-Chuang
700 1 _aWu, Xue-Zhen
700 1 _aZhu, Xiao-Jie
700 1 _aFan, Huo-Liang
700 1 _aFan, Xiang-Ping
700 1 _aXu, Jun-Fa
773 0 _tMolecular carcinogenesis
_gvol. 59
_gno. 4
_gp. 447-461
856 4 0 _uhttps://doi.org/10.1002/mc.23167
_zAvailable from publisher's website
999 _c30671109
_d30671109